Moderna lifts annual revenue forecast on strong COVID vaccine demand overseas

2

Nov 6 (Reuters) – Moderna lifted its full-year revenue forecast on Friday, after strong international demand for its COVID-19 vaccine and payments from partnerships helped the biotech swing to profit

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)